Cargando…
Alterations in dopamine system and in its connectivity with serotonin in a rat model of Alzheimer’s disease
Dopamine pathways alterations are reported in Alzheimer’s disease. However, it is difficult in humans to establish when these deficits appear and their impact in the course of Alzheimer’s disease. In the TgF344-Alzheimer’s disease rat model at the age of 6 months, we showed a reduction in in vivo re...
Autores principales: | Ceyzériat, Kelly, Gloria, Yesica, Tsartsalis, Stergios, Fossey, Christine, Cailly, Thomas, Fabis, Frédéric, Millet, Philippe, Tournier, Benjamin B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287930/ https://www.ncbi.nlm.nih.gov/pubmed/34286270 http://dx.doi.org/10.1093/braincomms/fcab029 |
Ejemplares similares
-
Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer’s disease
por: Gloria, Yesica, et al.
Publicado: (2021) -
In Vivo TSPO Signal and Neuroinflammation in Alzheimer’s Disease
por: Tournier, Benjamin B., et al.
Publicado: (2020) -
Reactive astrocytes mediate TSPO overexpression in response to sustained CNTF exposure in the rat striatum
por: Ceyzériat, Kelly, et al.
Publicado: (2023) -
Low-dose brain irradiation normalizes TSPO and CLUSTERIN levels and promotes the non-amyloidogenic pathway in pre-symptomatic TgF344-AD rats
por: Ceyzériat, Kelly, et al.
Publicado: (2022) -
Astrocytic TSPO Upregulation Appears Before Microglial TSPO in Alzheimer’s Disease
por: Tournier, Benjamin B., et al.
Publicado: (2020)